PARP1 and breast carcinoma: Interestingly, previous studies have also indicated that c-Met associated with and phosphorylated PARP-1 at Tyr907, and targeting both t c-Met and PARP-1 could synergize to suppress the growth of breast cancer cells both in vitro and in vivo.